Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maolactin is a dietary supplement under investigation for its effects on exercise recovery, inflammation, muscle comfort, and gastrointestinal health. It is being studied in randomized controlled trials for conditions such as sarcopenia (age-related muscle loss), polymyositis (an inflammatory muscle disease), muscle pain, and gastrointestinal dysfunction. The product appears to be developed by the company Maolac and marketed under names like "Maolactin FMR" for musculoskeletal benefits and "Maolactin-GI" for gut health. Its mechanism of action is not fully elucidated but it is positioned as an anti-inflammatory supplement that may support immune barrier function in the gut and reduce post-exercise inflammation[1][2][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on maolactin.